Are disease management, patient education or value based payment cost efficient?
In the medicare experience results were mitigated and barely paid the program’s fees. You can read the brief that has been issued by the Congressional Budget Office‘s health and Human Resources division:
and the blog that discusses the report:
In France a program of disease management and care coordination has been implemented. Its name is Sophia and it targets two chronic diseases, asthma and diabetes mellitus. More information here:
But I can’t find any evaluation of the kind of the CBO report that searches if the health care cost savings, inherent to the program, balance the program’s fees. If you have found such a report let me know.